226 related articles for article (PubMed ID: 31065120)
21. Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
Nissi R; Santala M; Immonen E; Talvensaari-Mattila A
Arch Gynecol Obstet; 2016 Nov; 294(6):1243-1247. PubMed ID: 27522599
[TBL] [Abstract][Full Text] [Related]
22. Mifepristone and oral, vaginal, or sublingual misoprostol for second-trimester abortion: a randomized controlled trial.
Dickinson JE; Jennings BG; Doherty DA
Obstet Gynecol; 2014 Jun; 123(6):1162-1168. PubMed ID: 24807339
[TBL] [Abstract][Full Text] [Related]
23. Second trimester medical abortion in a primigravida with lupus nephritis and rapidly progressive renal failure: challenges and outcome.
Bagga R; Sharma B; Choudhary N; Singla R; Saha PK; Bharati J; Rajkumar Kopp C; Jain S
Eur J Contracept Reprod Health Care; 2021 Apr; 26(2):171-173. PubMed ID: 33615941
[TBL] [Abstract][Full Text] [Related]
24. Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study.
Shay RL; Benson LS; Lokken EM; Micks EA
Contraception; 2022 Mar; 107():29-35. PubMed ID: 34529952
[TBL] [Abstract][Full Text] [Related]
25. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
Dickinson JE; Brownell P; McGinnis K; Nathan EA
Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
[TBL] [Abstract][Full Text] [Related]
26. Consistency of medical abortion efficacy from 5 through 14 weeks' gestation.
Garbin O; Vayssiere C; Bettahar-Lebugle K; Nisand I
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):36-40. PubMed ID: 16325992
[TBL] [Abstract][Full Text] [Related]
27. Medication abortion.
Bartz D; Goldberg A
Clin Obstet Gynecol; 2009 Jun; 52(2):140-50. PubMed ID: 19407520
[TBL] [Abstract][Full Text] [Related]
28. The added value of mifepristone to non-surgical treatment regimens for uterine evacuation in case of early pregnancy failure: a systematic review of the literature.
van den Berg J; Gordon BBM; Snijders MPML; Vandenbussche FPHA; Coppus SFPJ
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():18-26. PubMed ID: 26461963
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandins for induction of second-trimester termination and intrauterine death.
Ngai SW; Tang OS; Ho PC
Best Pract Res Clin Obstet Gynaecol; 2003 Oct; 17(5):765-75. PubMed ID: 12972013
[TBL] [Abstract][Full Text] [Related]
30. Medical methods for first trimester abortion.
Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
Cochrane Database Syst Rev; 2004; (2):CD002855. PubMed ID: 15106180
[TBL] [Abstract][Full Text] [Related]
31. Medical methods for first trimester abortion.
Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
[TBL] [Abstract][Full Text] [Related]
32. [Medical termination of pregnancy at 9-14 weeks gestation. Prospective study of 105 cases in Saint-Laurent-du-Maroni (French Guyana)].
Largeaud M; El Guindi W; Perotti F; Montoya Y; Carles G; Seve B
J Gynecol Obstet Biol Reprod (Paris); 2004 Apr; 33(2):119-24. PubMed ID: 15052177
[TBL] [Abstract][Full Text] [Related]
33. One- and 2-day mifepristone-misoprostol intervals are both effective in medical termination of second-trimester pregnancy.
Heikinheimo O; Suhonen S; Haukkamaa M
Reprod Biomed Online; 2004 Feb; 8(2):236-9. PubMed ID: 14989807
[TBL] [Abstract][Full Text] [Related]
34. Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.
Sonalkar S; Koelper N; Creinin MD; Atrio JM; Sammel MD; McAllister A; Schreiber CA
Am J Obstet Gynecol; 2020 Oct; 223(4):551.e1-551.e7. PubMed ID: 32305259
[TBL] [Abstract][Full Text] [Related]
35. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
Rose SB; Shand C; Simmons A
Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
[TBL] [Abstract][Full Text] [Related]
36. Medical abortion in combination with laminaria for first-trimester termination of pregnancy.
Chen HJ; Lin YH; Hwang JL
Int J Gynaecol Obstet; 2004 Jun; 85(3):279-80. PubMed ID: 15145268
[No Abstract] [Full Text] [Related]
37. Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study.
Henkel A; Lerma K; Blumenthal PD; Shaw KA
Contraception; 2020 Nov; 102(5):327-331. PubMed ID: 32592800
[TBL] [Abstract][Full Text] [Related]
38. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
Goldstone P; Michelson J; Williamson E
Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
[TBL] [Abstract][Full Text] [Related]
39. A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol for abortion at 14-21 weeks of pregnancy.
Dabash R; Chelli H; Hajri S; Shochet T; Raghavan S; Winikoff B
Int J Gynaecol Obstet; 2015 Jul; 130(1):40-4. PubMed ID: 25896965
[TBL] [Abstract][Full Text] [Related]
40. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation.
Tang OS; Chan CC; Ng EH; Lee SW; Ho PC
Hum Reprod; 2003 Nov; 18(11):2315-8. PubMed ID: 14585880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
